Hyperphosphorylation results in tau dysfunction in DNA folding and protection

Journal of Alzheimer's Disease

Volumn 37, Issue 3, 2013, Pages 551-563

  Lu, Yang ^a,b   He, Hai Jin ^b   Zhou, Jun ^b,d   Miao, Jun Ye ^b,d   Lu, Jing ^a   He, Ying Ge ^a   Pan, Rong ^a   Wei, Yan ^a   Liu, Ying ^a   He, Rong Qiao ^a,c  

^a INSTITUTE OF BIOPHYSICS   (China)

^b UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^c INSTITUTE OF PSYCHOLOGY   (China)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Alzheimer's disease; DNA protection; formaldehyde; GSK 3 ; phosphorylation; tau hyperphosphorylation; tau protein; tauopathy

Indexed keywords

FORMALDEHYDE; HISTONE H1; REACTIVE OXYGEN METABOLITE; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BASE PAIRING; CELL ADHESION; CELL NUCLEUS; CELL VIABILITY; CHROMATIN; CONTROLLED STUDY; DNA BINDING; DNA DAMAGE; DNA DENATURATION; DNA STRAND; DNA STRUCTURE; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; MICROTUBULE; MOUSE; NICK END LABELING; NONHUMAN; NUCLEIC ACID RENATURATION; PRIORITY JOURNAL; PROTECTION; PROTEIN DNA INTERACTION; PROTEIN FUNCTION; PROTEIN HYPERPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION;

ANIMALS; CELL LINE, TUMOR; DNA; HUMANS; MICE; PHOSPHORYLATION; PROTEIN DENATURATION; PROTEIN FOLDING; RATS; RATS, SPRAGUE-DAWLEY; TAU PROTEINS;

EID: 84892747392     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130602     Document Type: Article

References (77)

1. Stoothoff WH, Johnson GV (2005) Tau phosphorylation: Physiological and pathological consequences. Biochim Bio-phys Acta 1739, 280-297.
2. Weingarten MD, Lockwood AH, Hwo SY, Kirschner MW (1975) A protein factor essential for microtubule assembly. Proc Natl Acad Sci USA 72, 1858-1862.
3. Drechsel DN, Hyman AA, Cobb MH, Kirschner MW (1992) Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. Mol Biol Cell 3, 1141-1154.
4. Gotz J, Ittner LM, Kins S (2006) Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease? J Neurochem 98, 993-1006.
5. Hua Q, He RQ (2003) Tau could protect DNA double helix structure. Biochim Biophys Acta 1645, 205-211.
6. Qu MH, Li H, Tian R, Nie CL, Liu Y, Han BS, He RQ (2004) Neuronal tau induces DNA conformational changes observed by atomic force microscopy. Neuroreport 15, 2723-2727.
7. Ugolini G, Cattaneo A, Novak M (1997) Co-localization of truncated tau and DNA fragmentation in Alzheimer's disease neurones. Neuroreport 8, 3709-3712.
8. Sultan A, Nesslany F, Violet M, Begard S, Loyens A, Talahari S, Mansuroglu Z, Marzin D, Sergeant N, Humez S, Colin M, Bonnefoy E, Buee L, Galas MC (2011) Nuclear tau, a key player in neuronal DNA protection. J Biol Chem 286, 4566-4575.
9. Wei Y, Qu MH, Wang XS, Chen L, Wang DL, Liu Y, Hua Q, He RQ (2008) Binding to the minor groove of the double-strand, tau protein prevents DNA from damagebyperoxidation. PLoS One 3, e2600.
10. Buee L, Delacourte A (2006) [Tauopathy and Alzheimer disease: A full degenerating process]. Psychol Neuropsychiatr Vieil 4, 261-273.
11. Geschwind DH (2003) Tau phosphorylation, tangles, and neu-rodegeneration: The chicken or the egg? Neuron 40, 457-460.
12. Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2005) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur J Neurosci 22, 1942-1950.
13. Chen F, David D, Ferrari A, Gotz J (2004) Posttranslational modifications of tau-Role in human tauopathies and modeling in transgenic animals. Curr Drug Targets 5, 503-515.
14. Alonso A, Zaidi T, Novak M, Grundke-Iqbal I, Iqbal K (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc Natl Acad Sci USA 98, 6923-6928.
15. Feijoo C, Campbell DG, Jakes R, Goedert M, Cuenda A (2005) Evidence that phosphorylation of the microtubule-associated protein TaubySAPK4/p38 deltaatThr50promotes microtubule assembly. J Cell Sci 118, 397-408.
16. Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H, Van Leuven F (2008) Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice. Am J Pathol 172, 786-798.
17. Iqbal K, Alonso Adel C, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon S, Li B, Liu F, Rahman A, Tanimukai H, Grundke-Iqbal I (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 1739, 198-210.
18. Gotz J, Gladbach A, Pennanen L, van Eersel J, Schild A, David D, Ittner LM (2010) Animal models reveal role for tau phosphorylation in human disease. Biochim Biophys Acta 1802, 860-871.
19. Alonso AC, Li B, Grundke-Iqbal I, Iqbal K (2008) Mechanism of tau-induced neurodegeneration in Alzheimer disease and related tauopathies. Curr Alzheimer Res 5, 375-384.
20. Goedert M, Jakes R, Spillantini MG, Hasegawa M, Smith MJ, Crowther RA (1996) Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sul-phated glycosaminoglycans. Nature 383, 550-553.
21. Hardy J (2006) A hundred years of Alzheimer's disease research. Neuron 52, 3-13.
22. Wu YH, Feenstra MGP, Zhou JN, Liu RY, Torano JS, Van Kan HJM, Fischer DF, Ravid R, Swaab DF (2003) Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: Alterations in preclinical and clinical stages. J Clin Endocrinol Metab 88, 5898-5906.
23. Binder LI, Guillozet-Bongaarts AL, Garcia-Sierra F, Berry RW (2005) Tau, tangles, and Alzheimer's disease. Biochim Biophys Acta 1739, 216-223.
24. Wang JZ, Tian Q (2012) Molecular mechanisms underlie Alzheimer-like tau hyperphosphorylation and neurodegener-ation. Prog Biochem Biophys 39, 771-777.
25. Wei Y, Chen L, Chen J, Ge L, He RQ (2009) Rapid glycation with D-ribose induces globular amyloid-like aggregations of BSA with high cytotoxicityto SH-SY5Y cells. BMC Cell Biol 10, 10.
26. Hu JJ, Sun C, Lan L, Chen YW, Li DG (2010) Therapeutic effect of transplanting beta (2) m (-)/Thy1 (+) bone marrow-derived hepatocyte stem cells transduced with lentiviral-mediatedHGF gene intoCCl (4)-injured rats. J Gene Med 12, 244-254.
27. Lan L, Chen YW, Sun C, Liu BW, Sun QL, Li DG (2009) Effect of interleukin 10 gene-modified bone marrow-derived liver stem cells transplantation on hepatic inflammatory response and liver regeneration in hepatic fibrosis rats. Zhonghua Gan Zang Bing Za Zhi 17, 915-920.
28. Langbaum JB, Fleisher AS, Chen K, Ayutyanont N, Lopera F, Quiroz YT, Caselli RJ, Tariot PN, Reiman EM (2013) Ushering in the study and treatment of preclinical Alzheimer disease. Nat Rev Neurol 9, 371-381.
29. He RQ (2012) The research window of Alzheimer's disease should be brought forward. Prog Biochem Biophys 39, 692-697.
30. Lu J, Miao J, Su T, Liu Y, He R (2013) Formaldehyde induces hyperphosphorylation and polymerization of Tau protein both in vitro and in vivo. Biochim Biophys Acta 1830, 4102-4116.
31. Elyaman W, Terro F, Wong NS, Hugon J (2002) In vivo activation and nuclear translocation of phosphorylated glycogen synthase kinase-3 beta in neuronal apoptosis: Links to tau phosphorylation. Eur J Neurosci 15, 651-660.
32. Elyaman W, Yardin C, Hugon J (2002) Involvement of glycogen synthase kinase-3 beta and tau phosphorylation in neuronal Golgi disassembly. J Neurochem 81, 870-880.
33. Noble W, Planel E, Zehr C, Olm V, Meyerson J, Suleman F, Gaynor K, Wang L, LaFrancois J, Feinstein B, Burns M, Krishnamurthy P, Wen Y, Bhat R, Lewis J, Dickson D, Duff K (2005) Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci USA 102, 6990-6995.
34. Gao X, Joselin AP, Wang L, Kar A, Ray P, Bateman A, Goate AM, Wu JY (2010) Progranulin promotes neurite outgrowth and neuronal differentiation by regulating GSK-3 beta. Protein Cell 1, 552-562.
35. He RQ, Lu J, Mia JY (2010) Formaldehyde stress. Sci China Life Sci 53, 1399-1404.
36. Tong ZQ, Zhang JL, Luo WH, Wang WS, Li FX, Li H, Luo HJ, Lu J, Zhou JN, Wan Y, He RQ (2011) Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia. Neurobiol Aging 32, 31-41.
37. Nie CL, Zhang W, Zhang D, He RQ (2005) Changes in conformation of human neuronal tau during denaturation in formaldehyde solution. Protein Pept Lett 12, 75-78.
38. Nie CL, Wei Y, Chen XY, Liu YY, Dui W, Liu Y, Davies MC, Tendler SJB, He RG (2007) Formaldehyde at low concentration induces protein tau into globular amyloid-like aggregates in vitro and in vivo. PLoS One 2, e629.
39. Nie CL, Wang XS, Liu Y, Perrett S, He RQ (2007) Amyloidlike aggregates of neuronal tau induced by formaldehyde promote apoptosis of neuronal cells. BMC Neurosci 8, 9.
40. Hua Q, He RQ (2002) Effect of phosphorylation and aggregation on tau binding to DNA. Protein Pept Lett 9, 349-357.
41. Tong Z, Han C, Luo W, Wang X, Li H, Luo H, Zhou J, Qi J, He R (2012) Accumulated hippocampal formaldehyde induces age-dependent memory decline. Age (Dordr) 35, 583-596.
42. Gong CX, Liu F, Grundke-Iqbal I, Iqbal K (2005) Post-translational modifications of tau protein in Alzheimer's disease. J Neural Transm 112, 813-838.
43. Li T, Paudel HK (2006) Glycogen synthase kinase 3 beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism. Biochemistry 45, 3125-3133.
44. Liu F, Iqbal K, Grundke-Iqbal I, Rossie S, Gong CX (2005) Dephosphorylation of tau by protein phosphatase 5: Impairment in Alzheimer's disease. J Biol Chem 280, 1790-1796.
45. Blennow K (2005) CSF biomarkers for Alzheimer's disease: Use in early diagnosis and evaluation of drug treatment. Expert Rev Mol Diagn 5, 661-672.
46. Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B, Rosengren L, Vanmechelen E, Blennow K (2005) Simultaneous measurement of beta-amyloid (1-42), total tau, and phosphorylated tau (Thr (181)) in cerebrospinal fluid by the xMAP technology. Clin Chem 51, 336-345.
47. De Meyer G, Shapiro F, Vanderstichele H, Vanmechelen E, Engelborghs S, De Deyn PP, Coart E, Hansson O, Minthon L, Zetterberg H, Blennow K, Shaw L, Trojanowski JQ, Initi AsDN (2010) Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch Neurol 67, 949-956.
48. Abraha A, Ghoshal N, Gamblin TC, Cryns V, Berry RW, Kuret J, Binder LI (2000) C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. J Cell Sci 113, 3737-3745.
49. Michel G, Mercken M, Murayama M, Noguchi K, Ishiguro K, Imahori K, Takashima A (1998) Characterization of tau phos-phorylation in glycogen synthase kinase-3 beta and cyclin dependent kinase-5 activator (p23) transfected cells. Biochim Biophys Acta 1380, 177-182.
50. Li P, He X, Gerrero MR, Mok M, Aggarwal A, Rosenfeld MG (1993) Spacing and orientation of bipartite DNA-binding motifs as potential functional determinants for Pou domain factors. Genes Dev 7, 2483-2496.
51. Hua Q, He RQ, Haque N, Qu MH, Alonso AD, Grundke-Iqbal I, Iqbal K (2003) Microtubule associated protein tau binds to double-stranded but not single-stranded DNA. Cell Mol Life Sci 60, 413-421.
52. Petro KA, Schengrund CL (2009) Membrane raft disruption promotes axonogenesis in N2a neuroblastoma cells. Neu-rochem Res 34, 29-37.
53. Ikonen M, Liu BR, Hashimoto Y, Ma LQ, Lee KW, Niikura T, Nishimoto I, Cohen P (2003) Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein-3 regulates cell survival and apoptosis. Proc Natl Acad Sci USA 100, 13042-13047.
54. Misawa A, Inoue J, Sugino Y, Hosoi H, Sugimoto T, Hosoda F, Ohki N, Imoto I, Inazawa J (2005) Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplification. Cancer Res 65, 10233-10242.
55. Linask KK, Han MD, Cai DH, Brauer PR, Maisastry SM (2005) Cardiac morphogenesis: Matrix metalloproteinase coordination of cellular mechanisms underlying heart tube formation and directionality of looping. Dev Dyn 233, 739-753.
56. Xu GJ, Tsou CL (1964) Kinetics of effect of inhibitors on systems involving 2 enzyme-substrate intermediates. Sci Sin 13, 269-277.
57. Tan GS, Garchow BG, Liu XH, Yeung J, Morris JP, Cuellar TL, McManus MT, Kiriakidou M (2009) Expanded RNA-binding activities of mammalian Argonaute 2. Nucleic Acids Res 37, 7533-7545.
58. Noll M, Thomas JO, Kornberg RD (1975) Preparation of native chromatin and damage caused by shearing. Science 187, 1203-1206.
59. Thoma F, Koller T, Klug A (1979) Involvement of histone H1 in the organization of the nucleosome and of the salt-dependent superstructures of chromatin. J Cell Biol 83, 403-427.
60. Dedon PC, Soults JA, Allis CD, Gorovsky MA (1991) Formaldehyde cross-linking and immunoprecipitation demonstrate developmental-changes in H1-association with transcriptionally active genes. Mol Cell Biol 11, 1729-1733.
61. Vollenweider HJ, Sogo JM, Koller T (1975) A routine method for protein-free spreading of double-and single-stranded nucleic acid molecules. Proc Natl Acad Sci USA 72, 83-87.
62. Ma WJ, Cao EH, Zhang J, Qin JF (1998) Phenanthroline-Cu complex-mediated chemiluminescenceofDNA and its potential use in antioxidation evaluation. J Photochem Photobiol B 44, 63-68.
63. Xu YJ, Qiang M, Zhang JL, Liu Y, He RQ (2012) Reactive car-bonyl compounds (RCCs) cause aggregation and dysfunction of fibrinogen. Protein Cell 3, 627-640.
64. Lu J, Miao JY, Pan R, He RQ (2011) Formaldehyde-mediated hyperphosphorylation disturbs the interaction between tau protein and DNA. Prog Biochem Biophys 38, 1113-1120.
65. Travers AA, Ner SS, Churchill MEA (1994) DNA chaperones-a solution to a persistence problem. Cell 77, 167-169.
66. Jensen DE, Vonhippel PH (1976) DNA melting proteins 1. Effects of bovine pancreatic ribonuclease binding on conformation and stability of DNA. J Biol Chem 251, 7198-7214.
67. Thomas JO, Travers AA (2001) HMG1 and 2, and related 'architectural' DNA-binding proteins. Trends Biochem Sci 26, 167-174.
68. Alonso AD, Zaidi T, Novak M, Barra HS, Grundke-Iqbal I, Iqbal K (2001) Interaction of tau isoforms with Alzheimer's disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein. J Biol Chem 276, 37967-37973.
69. Ganem NJ, Pellman D (2012) Linking abnormal mitosis to the acquisition of DNA damage. J Cell Biol 199, 871-881.
70. Brooks SC, Adhikary S, Rubinson EH, Eichman BF (2013) Recent advances in the structural mechanisms of DNA gly-cosylases. Biochim Biophys Acta 1834, 247-271.
71. Kurdistani SK, Grunstein M (2003) In vivo protein-protein and protein-DNA crosslinking for genomewide binding microarray. Methods 31, 90-95.
72. Toth J, Biggin MD (2000) The specificity of protein-DNA crosslinking by formaldehyde: In vitro and in drosophila embryos. Nucleic Acids Res 28, e4.
73. Pitten FA, Kramer A, Herrmann K, Bremer I, Koch S (2000) Formaldehyde neurotoxicity in animal experiments. Pathol Res Pract 196, 193-198.
74. Kilburn KH, Warshaw R, Thornton JC (1987) formaldehyde impairs memory, equilibrium, and dexterity in histology technicians-effects which persist for days after exposure. Arch Environ Health 42, 117-120.
75. Perna RB, Bordini EJ, Deinzer-Lifrak M (2001) A case of claimed persistent neuropsychological sequelae of chronic formaldehyde exposure-Clinical, psychometric, and functional findings. Arch Clin Neuropsychol 16, 33-44.
76. Kuhla B, Luth HJ, Haferburg D, Boeck K, Arendt T, Munch G (2005) Methylglyoxal, glyoxal, and their detoxification in Alzheimer's disease. Ann N Y Acad Sci 1043, 211-216.
77. Ono K, Noguchi M, Matsumoto Y, Yanase D, Iwasa K, Naiki H, Yamada M (2005) Cerebrospinal fluid of Alzheimer patients promotes beta-amyloid fibril formation in vitro. Neu-robiol Dis 20, 233-240.